[1] CHEN L, MAGLIANO D J, ZIMMET P Z. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives[J].Nat Rev Endocrinol,2011,8(4):228-236.
[2] GOULDING A, JONES I E, TAYLOR R W,et al. Bone mineral density and body composition in boys with distal forearm fractures: a dualenergy x-ray absorptiometry study[J].J Pediatr,2001, 139(4):509-515.
[3] 蓝晓步,周刚,孙玉红.糖尿病并发症的发病机制及其药物治疗研究进展[J].临床合理用药杂志,2021,14(5):178-181.
[4] 陶桂香,徐洋.1型糖尿病发病机制及治疗研究[J].中国免疫学杂志,2015,31(10):1297-1303.
[5] 朱婉璐,佘重阳,白向丽,等.2型糖尿病患者对糖尿病视网膜病变的认知状况及其与视网膜病变严重程度的相关性研究[J].眼科,2018,27(3):225-230.
[6] 殷洪波,于攀,李杰.糖尿病肾病足细胞损伤机制研究进展[J].解放军医药杂志,2018,30(3):113-116.
[7] 刘莉莉,陈飞,谢希.糖尿病肾病诊断及治疗研究进展[J].医学综述,2020,26(6):1188-1192.
[8] ZHANG P , LIAO J , WANG X , et al. High glucose promotes apoptosis and autophagy of MC3T3-E1 osteoblasts[J].Arch Med Sci,2020, 19(1):138-150.
[9] ALMEIDA M , HAN L , AMBROGINI E , et al. Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens[J].Mol Endocrinol,2010, 24(10):2030-2037.
[10] GORDON L I , BURKE M A , SINGH A T K , et al. Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways[J].J Biol Chem,2009, 284(4):2080-2087.
[11] ARAI M , SHIBATA Y , PUGDEE K , et al. Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells[J].IUBMB Life,2010, 59(1):27-33.
[12] NARIMIYA T , KANZAKI H , YAMAGUCHI Y,et al.Nrf2 activation in osteoblasts suppresses osteoclastogenesis via inhibiting IL-6 expression[J].Bone Reports,2019, 11:100228.
[13] 吕本根,张元统,祁洪锋. 血清LDL-C、IL-6水平与2型糖尿病患者继发骨质疏松症的相关性[J].湖北民族大学学报(医学版),2023,40(4):34-37.
[14] KITAURA H, MARAHLEH A, OHORI F,et al. Osteocyte-related cytokines regulate osteoclast formation and bone resorption[J].Int J Mol Sci,2020,21(14):5169.
[15] 叶丹. 炎症反应相关因子与2型糖尿病[J].国外医学·内分泌学分册, 2003, 23(5):312-314.
[16] 刘燕,马刚,王友强,等.2型糖尿病合并骨质疏松患者DEXA骨密度测量结果与脂联素,瘦素,胰岛素抵抗的关系[J].中国实用医药,2021,16(12):100-103.
[17] ZHAN J K ,WANG Y J ,WANG Y , et al. Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway[J].Exp Cell Res,2014, 323(2):352-358.
[18] 姜艳静, 孙亚东, 马彦,等. 血清脂肪因子Apelin水平与2型糖尿病视网膜病变的相关性研究[J].中国保健营养,2021,31(9): 25.
[19] 陈燕. 脂肪因子vaspin与2型糖尿病关系的研究[D]. 重庆:重庆医科大学, 2012.
[20] LOKE Y K, SINGH S, FURBERG C D. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a Meta-analysis[J].CMAJ,2009, 180(1):32-39.
[21] 郑盼盼,赵维丽,胡庆山,等.2型糖尿病合并代谢相关脂肪性肝病影响因素的研究[J].中国糖尿病杂志,2023,31(2):99-103.
[22] 易茜,于明.糖尿病视网膜病变的发病机制[J].复旦学报(医学版),2010,37(5):604-607.
[23] 杨明明,张友生,姚媛莉,等.利拉鲁肽联合阿仑膦酸钠治疗2型糖尿病合并骨质疏松症的效果[J].西北药学杂志,2024,39(6):212-216.
[24] 刘瑞琦,王东凯.双膦酸盐类抗骨质疏松药物研究进展[J].中国药剂学杂志(网络版),2023,21(2):103-115.
[25] 曹树业,薛雷,高洪达.鲑鱼降钙素联合神经生长因子对膝关节术后骨密度、炎症水平的影响[J].医学理论与实践,2023,36(9):1512-1514.
[26] 罗娜,孙般若,李春霖.性激素在老年男性骨质疏松发病及治疗中作用的研究进展[J].中国骨质疏松杂志,2021,27(12):1859-1862.
[27] 赵丽艳,王晓婧,陈龙,等.骨质疏松治疗中抗骨吸收药物的作用机制[J].中国老年学杂志,2010,30(20):3025-3027.
[28] 孙丽莎,刘润萍,陈秋.糖尿病合并骨质疏松症的发病机制及治疗[J].山东医药,2012,52(17):92-95.
[29] 曲静,张东鹏.糖尿病性骨质疏松症中医药治疗研究进展[J].中国药物经济学,2024,19(8):117-121.
[30] SHERK V D , ROSEN C J .Senescent and apoptotic osteocytes and aging: Exercise to the rescue?[J].Bone,2019, 121:255-258. |
2024, Vol. 41 
